cbdMD, Inc. - stock earnings
YCBD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -996501 USD | 5.4 million USD |
| 2023Q3 | -15.9 million USD | 5.7 million USD |
| 2023Q2 | -1.8 million USD | 6.1 million USD |
| 2023Q1 | 60.6 million USD | 6.2 million USD |
| 2022Q4 | -5.0 million USD | 6.1 million USD |
| 2022Q3 | -16.6 million USD | 7.9 million USD |
| 2022Q2 | -32.6 million USD | 8.6 million USD |
| 2022Q1 | -4.3 million USD | 9.6 million USD |
| 2021Q4 | -19.2 million USD | 9.3 million USD |
| 2021Q3 | -3.0 million USD | 9.8 million USD |
| 2021Q2 | 1.5 million USD | 10.6 million USD |
| 2021Q1 | -12.5 million USD | 11.8 million USD |
| 2020Q4 | -9.4 million USD | 12.3 million USD |
| 2020Q3 | -6.3 million USD | 11.7 million USD |
| 2020Q2 | -9.0 million USD | 10.6 million USD |
| 2020Q1 | 14.9 million USD | 9.4 million USD |
| 2019Q4 | 12.9 million USD | 10.1 million USD |
| 2019Q3 | 11.2 million USD | 8.7 million USD |
| 2019Q2 | -27.7 million USD | 8.0 million USD |
| 2019Q1 | -31.8 million USD | 5.7 million USD |
| 2018Q4 | -584385 USD | 1.2 million USD |
| 2018Q3 | -889617 USD | 1.5 million USD |
| 2018Q2 | 206074 USD | 3.2 million USD |
| 2018Q1 | 1.4 million USD | 3.1 million USD |
| 2017Q4 | -1.1 million USD | 687756 USD |
| 2017Q3 | -338328 USD | 1.1 million USD |
| 2017Q2 | -210690 USD | 1.8 million USD |
| 2017Q1 | -555237 USD | 1.4 million USD |
| 2016Q4 | -634479 USD | 199837 USD |
| 2016Q3 | -1.0 million USD | 230208 USD |
| 2016Q2 | -1.2 million USD | 385486 USD |
YCBD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.9 million USD | 24.2 million USD |
| 2022 | -74.1 million USD | 35.4 million USD |
| 2021 | -23.4 million USD | 44.5 million USD |
| 2020 | 12.6 million USD | 41.9 million USD |
| 2019 | -45.4 million USD | 23.7 million USD |
| 2018 | -412075 USD | 8.4 million USD |
| 2017 | -1.7 million USD | 4.5 million USD |
| 2016 | -3.4 million USD | 2.0 million USD |
| 2015 | -1.1 million USD | 12540 USD |
YCBD
Price: $0.89
52 week price:
Earnings Per Share: -10.29 USD
P/E Ratio: -0.06
Exchange: ASE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 457300
Market Capitalization: 2.7 million